Hot flash drug gets a makeover: new pill forms tested

NCT ID NCT07229404

Completed Knowledge-focused Sponsor: Bayer Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage study tested how well new tablet versions of the drug elinzanetant are absorbed by the body compared to the original soft gel capsule. Eighteen healthy women took single and multiple doses of each form. The goal was to see if the new pills deliver the same amount of drug into the bloodstream, which could lead to a more convenient treatment option for hot flashes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Elinzanetant
What this could lead to: If successful, this could lead to a more convenient pill form of elinzanetant for treating hot flashes.
What could go wrong: This is a very early, small study in healthy women, not patients. It only measures drug levels in the blood, not whether the drug actually works for hot flashes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VASOMOTOR SYMPTOMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VASOMOTOR SYMPTOMS

Contacts and locations

Show contact details

Locations

Altasciences

Mount Royal, Quebec, H3P 3P1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.